Seeking Alpha

ISTA Pharmaceuticals (ISTA -5.3%) trades lower after reporting mixed results from its eye drug...

ISTA Pharmaceuticals (ISTA -5.3%) trades lower after reporting mixed results from its eye drug trials. Phase 3 studies to evaluate the short-term safety and efficacy of its drug Remura, a treatment for dry eye disease, showed it was effective but not statistically better than the placebo.
Comments (1)
  • TruffelPig
    , contributor
    Comments (4063) | Send Message
     
    If it isn't better than placebo we call that ineffective.
    13 Oct 2011, 01:14 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|